Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8853228
Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
granted -
US 8853244
Thiophene-carboxamides useful as inhibitors of protein kinases
granted -
US 8846908
Tricyclic carbamate JAK inhibitors
granted -
US 8846684
Arbovirus inhibitors and uses thereof
granted -
US 8846686
Compounds useful as inhibitors of ATR kinase
granted -
US 8846918
Compounds useful as inhibitors of ATR kinase
granted -
US 8846913
Neprilysin inhibitors
granted -
US 8846713
Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors
granted -
US 8846917
Compounds useful as inhibitors of ATR kinase
granted -
US 8841308
Pyrazin-2-amines useful as inhibitors of ATR kinase
granted -
US 8841288
Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases
granted -
US 8841483
Compositions useful as inhibitors of voltage-gated sodium channels
granted -
US 8841257
Inhibitors of STAT3 and uses thereof
granted -
US 8841295
5-lipoxygenase-activating protein (FLAP) inhibitors
granted -
US 8841450
Compounds useful as inhibitors of ATR kinase
granted -
US 8841449
Compounds useful as inhibitors of ATR kinase
granted -
US 8841337
Compounds useful as inhibitors of ATR kinase
granted -
US 8841302
HCV inhibitor and therapeutic agent combinations
granted -
US 8828356
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
granted -
US 8829007
Inhibitors of influenza viruses replication
granted -
US 8829187
Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase
granted -
US 8828977
Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor
granted -
US 8822469
Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase
granted -
US 8822698
Aminoacid derivatives, their process of preparation and their therapeutical uses as inhibitors of oncogenic signals by the Met family
granted